An antimalarial medicine-making project wins the inaugural Humanity in Science Award.

Information from “stalled” drug trials should be published, not tossed aside

Global healthcare company GlaxoSmithKline (GSK) has pledged to be carbon neutral by 2050.

A ‘robot scientist’, capable of independently carrying out drug screening research, has been developed by UK researchers.

Pharma companies look to new genetic screening technology to enhance drug discovery.

Research into rare diseases is on the rise, but are prices sustainable?

Research into rare diseases is on the rise, but are prices sustainable?

Why we need research in space? We spoke with Cynthia Bouthot at the Center for the Advancement of Science in Space (CASIS) to find out.

Is research into orphan diseases on the rise?

Who should pay for the disposal of unused medicines? Legal tussles continue over ‘drug takeback’ law in Californian county.